FSRH CEU Statement: Response to Heikinheimo 2022 (June 2022)

Published on: 22 June 2022

File size: 505kb PDF

File type: Clinical Statements

This FSRH Statement responses to a recently published cohort study, which used information from Finnish databases, assessed incidence of confirmed venous thromboembolic (VTE) events in 2018/19 amongst the roughly 300,000 Finnish people aged 15-49 who were using hormonal contraception (HC) in 2017 (identified from the prescribing database) and age-matched controls who were not using hormonal contraception.

Your download should start automatically. If not download directly.